Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Collaboration Key To The Widespread Adoption Of AI For Health Care

Executive Summary

Artificial intelligence (AI) vendors are partnering with health care providers to identify practical challenges and consider AI technology as a potential solution. This type of collaboration is crucial to successful AI adoption because the technology is designed to tackle real-world health care problems. A myriad of examples was displayed at the recent RSNA 2020 meeting.

You may also be interested in...



Addressable Market For Health Care AI ‘Vast But Largely Untapped’

Omdia estimates that in 2019, the global market for health care AI software was $823m, making it the sixth-largest industry for AI revenue, but only a small fraction of the $16bn total AI software market.

Ultrasound Market To Bounce Back In 2021; Pandemic Will Accelerate Adoption Of New Tech

Omdia expects revenue for ultrasound systems to contract by 8.4% in 2020, but to pick up again in 2021.

Topics

Related Companies

UsernamePublicRestriction

Register

RS150923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel